NLRP3, a pivotal member of the NLR (nucleotide-binding oligomerization domain-like receptor) family, is increasingly recognized as a promising therapeutic target for a spectrum of conditions, including allergies (18). This evidence concerns the gene NLRP3 and allergic disease.